(CON) Concentra Holdings Parent - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US20603L1026

CON: Health, Services, Care, Testing, Pharmacy, Wellness

Concentra Group Holdings Parent, Inc. (NYSE:CON) is a leading provider of occupational health services in the United States, focusing on delivering comprehensive healthcare solutions tailored for employers and employees. Their extensive range of services includes workers compensation injury care, urgent care, clinical testing, and preventative care programs, all designed to optimize workplace health and productivity.

The company stands out with its innovative telemedicine solution, Concentra Telemed, which offers remote consultations for work-related injuries and illnesses. This service not only enhances accessibility for employees but also streamlines healthcare delivery for employers, reducing downtime and associated costs. Additionally, Concentra provides pharmacy solutions under the Concentra Pharmacy name and compliance administration services, aiding employers in managing drug-testing programs efficiently, whether for regulated or non-regulated workforces.

As a subsidiary of Select Medical Corporation, Concentra benefits from the resources and expertise of one of the largest rehabilitation providers in the country. This affiliation underscores Concentras commitment to high-quality patient care and operational excellence, positioning it as a trusted partner in occupational health.

Financially, Concentra demonstrates robust market presence with a market capitalization of approximately $2.9 billion, reflecting its established position in the healthcare sector. The current P/E ratio of 22.67, coupled with a forward P/E of 18.05, suggests investor confidence and anticipated growth. A P/B ratio of 2.35 indicates a premium valuation relative to book value, while the P/S ratio of 1.57 highlights moderate revenue efficiency.

Headquartered in Mechanicsburg, Pennsylvania, and founded in 1979, Concentra has built a legacy of providing integrated occupational health solutions. Their approach not only addresses immediate healthcare needs but also emphasizes preventative measures and compliance, making them a holistic partner for employers seeking to foster a healthier, safer workforce. For more information, visit their website at https://www.concent

CON Stock Overview

Market Cap in USD 2,927m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2024-07-25

CON Stock Ratings

Growth Rating -30.0
Fundamental 28.2
Dividend Rating 17.4
Rel. Strength -0.77
Analysts 4.63/5
Fair Price Momentum 18.88 USD
Fair Price DCF 36.52 USD

CON Dividends

Dividend Yield 12m 0.60%
Yield on Cost 5y 0.56%
Annual Growth 5y 0.00%
Payout Consistency 100.0%

CON Growth Ratios

Growth Correlation 3m -78.7%
Growth Correlation 12m -23%
Growth Correlation 5y -23%
CAGR 5y -8.74%
CAGR/Max DD 5y -0.42
Sharpe Ratio 12m -0.79
Alpha -13.64
Beta 0.277
Volatility 36.42%
Current Volume 813.3k
Average Volume 20d 704k
What is the price of CON stocks?
As of April 19, 2025, the stock is trading at USD 20.39 with a total of 813,300 shares traded.
Over the past week, the price has changed by +0.49%, over one month by -2.21%, over three months by -8.29% and over the past year by -8.74%.
Is Concentra Holdings Parent a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Concentra Holdings Parent is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.23 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CON as of April 2025 is 18.88. This means that CON is currently overvalued and has a potential downside of -7.41%.
Is CON a buy, sell or hold?
Concentra Holdings Parent has received a consensus analysts rating of 4.63. Therefor, it is recommend to buy CON.
  • Strong Buy: 5
  • Buy: 3
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CON stock price target?
According to ValueRays Forecast Model, CON Concentra Holdings Parent will be worth about 20.4 in April 2026. The stock is currently trading at 20.39. This means that the stock has a potential upside of +0%.
Issuer Forecast Upside
Wallstreet Target Price 29.8 46.1%
Analysts Target Price 29.8 46.1%
ValueRay Target Price 20.4 0%